Nurix Therapeutics, Inc. (NRIX)
25.57
-0.47
(-1.80%)
USD |
NASDAQ |
Sep 02, 14:16
Nurix Therapeutics Net Income (TTM) : -341.35M for May 31, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| May 31, 2026 | -341.35M |
| February 28, 2026 | -295.28M |
| November 30, 2025 | -264.46M |
| August 31, 2025 | -244.78M |
| May 31, 2025 | -207.32M |
| February 28, 2025 | -208.40M |
| November 30, 2024 | -193.57M |
| August 31, 2024 | -176.98M |
| May 31, 2024 | -165.00M |
| February 29, 2024 | -144.73M |
| November 30, 2023 | -143.95M |
| August 31, 2023 | -148.71M |
| May 31, 2023 | -157.44M |
| February 28, 2023 | -178.56M |
| Date | Value |
|---|---|
| November 30, 2022 | -180.36M |
| August 31, 2022 | -171.34M |
| May 31, 2022 | -154.47M |
| February 28, 2022 | -135.45M |
| November 30, 2021 | -117.19M |
| August 31, 2021 | -99.41M |
| May 31, 2021 | -89.09M |
| February 28, 2021 | -55.13M |
| November 30, 2020 | -43.24M |
| August 31, 2020 | -36.85M |
| May 31, 2020 | -20.76M |
| February 29, 2020 | -31.40M |
| November 30, 2019 | -21.70M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Monte Rosa Therapeutics, Inc. | -161.12M |
| Gilead Sciences, Inc. | -3.24B |
| TG Therapeutics, Inc. | 441.49M |
| Cue Biopharma, Inc. | -164.11M |
| Keros Therapeutics, Inc. | -83.16M |